Title: A Clinical, Biochemical and Immunological Profile of Systemic Lupus Erythematosus in Adult Patients in a Tertiary Care Centre

Authors: Dr Varsha Bhatt, Dr Mitali Khadke, Dr Arjun Kakrani, Dr Love Garg, Dr Manaswini Edara

 DOI: https://dx.doi.org/10.18535/jmscr/v8i1.62

Abstract

Background: Systemic Lupus Erythematosus [SLE] is an autoimmune disease. Autoantibodies can be present in many patients for a few years before the 1st clinical symptom appears. Considerable variation has been observed regarding various clinical manifestation of SLE among various ethnic groups as well as various geographical regions. This study was done to elucidate, clinical presenting features and various systemic manifestations, the biochemical parameters, inflammatory markers and immunological profile of the adult SLE in patients presenting to medicine wards of tertiary care centre.

Methods: All the adult SLE patients aged 18 years and above attending medicine OPD or admitted in Department of General Medicine during the study period from September 2017 to August 2019 were included in the study.

Results: In the present study, male:female ratio was 21:1 with most common age group being affected was between 25-44 years. Musculoskeletal system (66.66%) followed by mucocutaneous system(64.44%) were most common systems affected in this study. 23(51.11%) patients had organ threatening lupus affecting kidney and brain. Out of these 23 patients, 43.4% didn’t have mucocutaneous or musculoskeletal involvement at all which posed diagnostic challenge. ANA was positive in all patients. Anti dsDNA was commonest autoantibody found in this study. According to SLEDAI, 44.4% patients presented with severe flare.

Conclusion: The majority of patients belonged to age group of 25-44 years with a female predilection and ANA was positive in all patients. Out of 23 patients which had major organ involvement at presentation 43.4% didn’t have mucocutaneous or musculoskeletal involvement at all.

Keywords: SLE, lupus nephritis, neuropsychiatric lupus.

References

  1. Binoy JP, Muhammed F, Kumar N, Razia MV. Clinical profile of systemic lupus erythematosus in North Kerala. J Indian RheumatolAssoc 2003;11:94-7.
  2. R. M. Andrade, G. S. Alarcón, M. Fernández, J. D. Reveille, and LUMINA Study Group, “Accelerated damage accrual among men with systemic lupus erythematosus: XLIV. Results from a multiethnic US cohort,” Arthritis & Rheumatism.2007:56 (2): 622–630
  1. Johnson AE, Gordon C, Palmer RG, Bacon PA. The prevalence and incidence of systemic lupus erythematosus in Birmingham. Engl Arthritis Rheumatol. 1995;38(4):551–558..
  2. Malaviya AN, Singh RR, Kumar A et al. SLE in Northern India. A review of 329 cases.   J AssocPhys India 1988; 36: 476-80.
  3. Cervera R et al. Systemic lupus erythematosus: clinical and immunological patterns of  disease expression in a cohort of 1000 patients. Medicine (Balt.) 1993;72: 113-124.
  4. Wong K.L. Pattern of SLE in Hong Kong Chinese: a cohort study. Scand J Rheumatol 1992; 21: 289-296.
  5. Al-Attia HM, George S. Characterization of systemic lupus erythematosus in patients in UAE. Clinical Rheumatology;l 14: 171-175
  6. Maloney, K. C., Ferguson, T. S., Stewart, H. D., Myers, A. A., De Ceulaer, K. Clinical and immunological characteristics of 150 systemic lupus erythematosus patients in Jamaica: a comparative analysis. Lupus.2017 26(13), 1448–1456.
  7. Shearn MA. The heart in systemic lupus erythmatosus. Am Heart J 1959; 58:452-466.

Corresponding Author

Dr Mitali Khadke

Department of General Medicine Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pimpri, Pune, India